The Early Detection of Colorectal Cancer Test Epi proColon®

Epi proColon is now the first and only FDA approved blood test for colorectal cancer screening.

Colorectal cancer (CRC) is treatable in more than 90% of cases if diagnosed early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the worldwide.

The dilemma: screening options such as colonoscopy and fecal occult blood testing exist, but patient compliance is low. The Epi proColon offers a convenient way of detecting colorectal cancer early: in blood. It's as simple as a blood draw.

More information on Epi proColon® can be found here.